Prof José Dirceu Ribeiro, PhD is an expert in Pediatrics at Hospital de Clínicas da Unicamp (Brazil). As of October 2026, ScienceLeadR ranks José Dirceu Ribeiro in the top 1% of experts in Brazil for Cystic Fibrosis and Pancreatic Diseases. José Dirceu Ribeiro has authored 240 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 653 (community average: 125). How the SLR is computed.

LeadR Profile

Prof José Dirceu Ribeiro, PhD Hospital de Clínicas da Unicamp Brazil
653 ScienceLeadR Reputation 653
Network Map

Pediatrics

Subspecialties: Pulmonology - Dentistry - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026

Source: PubMed

State University of Campinas

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 240

Citations

Citations: 5 263 1st author: 8 Last author: 87 Unique author: 3


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Hypokalemic Hypochloremic Metabolic Alkalosis in Cystic Fibrosis: A Retrospective Observational Study with Clinical Characterization, CFTR Genetic Profiling, and a Comparative Genetic Analysis with Patients from a Brazilian Reference Center.
PMID 42737565 — tertiary care centers, genes, fibrosis, cystic fibrosis, hypokalemia, alkalosis, genetic profile
Int J Mol Sci20260
Chronic rhinosinusitis association with small airway disease: Inflammatory biomarkers and lung function using impulse oscillometry.
PMID 42302462 — research design, lung, blood, eosinophils, biomarkers, spirometry, vital capacity, rhinosinusitis
Braz J Otorhinolaryngol20260
The role of ultrasound of the quadriceps femoris in people with cystic fibrosis: a systematic review and meta-analysis.
PMID 42307335 — bias, muscles, fibrosis, quadriceps muscle, cystic fibrosis
J Bras Pneumol20260
Assessment of abdominal symptoms and intestinal inflammation in children and adolescents with cystic fibrosis without highly effective modulator therapy.
PMID 42036102 — genes, fibrosis, pain, signs and symptoms, cystic fibrosis, adolescent, prevalence, therapeutics, pediatrics, child
J Pediatr (Rio J)20260
Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators.
PMID 41919747 — genes, respiratory system, fibrosis, cystic fibrosis transmembrane conductance regulator, cystic fibrosis, endoscopy, therapeutics, pediatrics
Pediatr Pulmonol20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Active not recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Exercise As Intervention in Chronic Lymphocytic Leukemia
NCT06396611 — exercise, cells, leukemia, lymphocytic, chronic, b-cell, leukemia, leukemia, lymphoid, resistance training, b-lymphocytes
N/AActive not recruiting2023

LeadR Networks

Main global connection map